ARTL
ARTELO BIOSCNCS (ARTL)
NASDAQ
$1.45-$0.01 (-1.03%)
Price as of Jun 03, 2026 7:59 PM EDT
  • $3.3M
    Market Cap
  • -92.63%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-5.4M
-9.51%
-6.0M
+5.21%
-5.7M
+31.73%
-4.3M
N/A
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
11.4M
+12.82%
10.1M
+1.79%
9.9M
-3.47%
10.3M
N/A
Operating Profit
-11.4M
+12.82%
-10.1M
+1.79%
-9.9M
-3.47%
-10.3M
N/A
Interest Income
22,000
N/A
N/A
N/A
0
-100.00%
2,000
N/A
Interest Expense
-194,000
N/A
N/A
N/A
0
+100.00%
-5,000
N/A
Interest Income and Expense and Net
-172,000
N/A
0
N/A
0
+100.00%
-3,000
N/A
Total Nonoperating Income and Expense
-1.5M
-623.05%
282,000
-56.01%
641,000
+214.22%
204,000
N/A
Income before Taxes
-11.4M
+12.82%
-10.1M
+1.79%
-9.9M
-3.47%
-10.3M
N/A
Income Taxes
0
N/A
0
N/A
0
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-12.9M
+31.07%
-9.8M
+5.78%
-9.3M
-7.87%
-10.1M
N/A
Net Income from Continuing Operations Applicable to Common
-12.9M
+31.07%
-9.8M
+5.78%
-9.3M
-7.87%
-10.1M
N/A
Basic EPS and Net Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Diluted EPS and Net Income
-12.52
+310.49%
-3.05
N/A
N/A
N/A
N/A
N/A
Basic Weighted Average Shares
1.0M
-68.07%
3.2M
N/A
N/A
N/A
N/A
N/A
Diluted Weighted Average Shares
1.0M
-68.07%
3.2M
N/A
N/A
N/A
N/A
N/A
Balance Sheet
Cash and Cash Equivalents
600,000
-74.34%
2.3M
-16.94%
2.8M
-59.13%
6.9M
-43.36%
Short-Term Investments
N/A
N/A
0
N/A
0
-100.00%
1.5M
-87.49%
Cash and Cash Equivalents and Short-Term Investments
600,000
-74.34%
2.3M
-16.94%
2.8M
-66.42%
8.4M
-65.23%
Total Current Assets
695,000
-72.82%
2.6M
-76.71%
11.0M
-40.07%
18.3M
-25.55%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
3,000
0.00%
3,000
0.00%
3,000
0.00%
3,000
-99.97%
Total Assets
2.8M
-40.38%
4.7M
-63.98%
13.0M
-36.14%
20.4M
-27.71%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
437,000
N/A
N/A
N/A
N/A
N/A
53,000
+152.38%
Total Current Liabilities
4.0M
+128.22%
1.8M
+37.26%
1.3M
+29.36%
998,000
-2.82%
Total Long-Term Debt
609,000
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
29,000
-57.97%
69,000
N/A
0
-100.00%
23,000
-59.65%
Total Liabilities
4.1M
+121.24%
1.8M
+42.60%
1.3M
+26.44%
1.0M
-5.81%
Retained Earnings
-63.0M
+25.69%
-50.1M
+24.38%
-40.3M
+29.94%
-31.0M
+48.16%
Total Stockholders Equity
-1.3M
-144.52%
2.9M
-75.69%
11.8M
-39.43%
19.4M
-28.58%
Total Shares Outstanding
2.0M
-38.47%
3.3M
+2.89%
3.2M
+11.67%
2.9M
-93.25%
Cash Flow
Cash from Operating Activities
-8.5M
+2.04%
-8.3M
+1.74%
-8.2M
+2.49%
-8.0M
N/A
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
-62,000
-100.80%
7.8M
+121.53%
3.5M
+18.56%
3.0M
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
6.9M
+6,031.25%
112,000
-80.25%
567,000
N/A
0
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-343.49%
+210.08%
-110.77%
+99.55%
-55.51%
N/A
N/A
N/A
Return on Equity
-1,625.11%
+1,108.08%
-134.52%
+125.59%
-59.63%
N/A
N/A
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
0.17
-88.09%
1.44
-83.03%
8.51
N/A
N/A
N/A
Cash Ratio
0.15
-88.75%
1.32
-39.49%
2.18
N/A
N/A
N/A
Debt-to-Equity Ratio
-0.82
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
0.37
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow